Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Non-small cell lung cancer

  • You have access
    Dual Biomarker Combining DNA Damage Repair Gene Mutations and PD-L1 Expression for Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    HYERA KIM, DONG HYUN LIM, YONG SHIK KWON, MI AE KIM and KEON UK PARK
    Anticancer Research May 2023, 43 (5) 2343-2349; DOI: https://doi.org/10.21873/anticanres.16399
  • Open Access
    Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer
    MASATOSHI NAKAMURA, HITOSHI ISHIKAWA, KAYOKO OHNISHI, KEIICHIRO BABA, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, YUICHI HIROSHIMA, MASASHI MIZUMOTO, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI
    Anticancer Research May 2023, 43 (5) 2003-2013; DOI: https://doi.org/10.21873/anticanres.16361
  • You have access
    Association of STAT3, CYP3A5, and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients
    MASAAKI TANDA, KAZUHIRO YAMAMOTO, TOMOKI HORI, HIROKI NISHIGUCHI, MIKI YAGI, MICHIKO SHIMIZU, TORU KONISHI, TOMONORI OZAKI, NATSUE YOSHIOKA, MOTOKO TACHIHARA, TAKEFUMI ITO, SHIGEKI IKUSHIMA, TOMOHIRO OMURA and IKUKO YANO
    Anticancer Research April 2023, 43 (4) 1775-1783; DOI: https://doi.org/10.21873/anticanres.16331
  • You have access
    Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
    AKIHIRO TAMIYA, MOTOHIRO TAMIYA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, YOSHINOBU MATSUDA, TAKAHISA KAWAMURA, KEI KUNIMASA, TAKAKO INOUE, KAZUMI NISHINO and KYOICHI OKISHIO
    Anticancer Research March 2023, 43 (3) 1325-1330; DOI: https://doi.org/10.21873/anticanres.16280
  • Open Access
    Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators
    JEROME H. CHECK, TRINA PORETTA, DIANE CHECK and MAYA SRIVASTAVA
    Anticancer Research March 2023, 43 (3) 951-965; DOI: https://doi.org/10.21873/anticanres.16240
  • Open Access
    Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer
    MIZUKI YAMAZAKI, NAO KOMIZO, HIROTOSHI IIHARA, CHIEMI HIROSE, KOMEI YANASE, YUTO YAMADA, JUNKI ENDO, SHUJI YAMASHITA, YASUSHI OHNO, KENICHIRO TODOROKI, AKIO SUZUKI and HIDEKI HAYASHI
    Anticancer Research February 2023, 43 (2) 725-732; DOI: https://doi.org/10.21873/anticanres.16211
  • Open Access
    The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer
    ALEKSANDRA PARTYNSKA, ALEKSANDRA PIOTROWSKA, KONRAD PAWELCZYK, ADAM RZECHONEK, KATARZYNA RATAJCZAK-WIELGOMAS, MARZENNA PODHORSKA-OKOLOW and PIOTR DZIEGIEL
    Anticancer Research December 2022, 42 (12) 5731-5741; DOI: https://doi.org/10.21873/anticanres.16080
  • Open Access
    A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer
    CHAE HONG LIM, YOUNG WHA KOH, SEUNG HYUP HYUN and SU JIN LEE
    Anticancer Research December 2022, 42 (12) 5875-5884; DOI: https://doi.org/10.21873/anticanres.16096
  • You have access
    Impact of Corticosteroids for IrAEs on the Clinical Outcome of Immunotherapy in Patients With NSCLC
    KAZUHIRO SHIMOMURA, TEPPEI YAMAGUCHI, YUKO OYA, KOSAKU UCHIDA and KENTA MUROTANI
    Anticancer Research December 2022, 42 (12) 5961-5969; DOI: https://doi.org/10.21873/anticanres.16106
  • You have access
    Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy
    YUSUKE TAKAYAMA, JUN YANO, REN SEIKE, SHOHEI MISHIMA and HIROYASU SHODA
    Anticancer Research October 2022, 42 (10) 4805-4812; DOI: https://doi.org/10.21873/anticanres.15985

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 19
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire